Investor · 1 deal
Perth, WA
Every published round Yuuwa Capital took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Polyactiva | Unnamed stage | 23 Jul 2019 | $10m | Participant | Brandon BioCatalyst portfolio, Brandon Capital portfolio |
Companies Yuuwa Capital has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Polyactiva | 23 Jul 2019 | 1 | 0 |
Fund closes reported for Yuuwa Capital, as distinct from the investments it has made.
Companies Yuuwa Capital has backed that another company then bought. An exit for the holding, not a deal Yuuwa Capital did.
| Name | Role | Sources |
|---|---|---|
| Matthew Macfarlane | Founder | functionly.com |
Stories naming Yuuwa Capital. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Two new Western Australian syndicates, West Tech Investor Network and VentureX Capital, have unveiled debut deals via the Aussie Angels platform, eyeing Procuracon and HeyLady; an earlier $100,000 outlay across three startups is recalled.
Also Startup News (WA)
Vancouver's Semios is buying Perth crop-data platform Agworld for a reported $100 million, a landmark exit for the local agtech scene and a windfall for early backer Yuuwa Capital.
PolyActiva's glaucoma implant was well tolerated in a Phase I trial and a Phase II study is underway; the Melbourne biotech is backed by Brandon Capital's MRCF and Yuuwa Capital.
Perth video analytics company iCetana completed its IPO on the ASX just before Christmas, becoming the first significant home-grown WA tech startup listing, with CEO Matt Macfarlane recounting its decade-long path from university research.
PolyActiva finished enrolling patients in its Phase I glaucoma implant trial and closed a AU$10 million raise from existing backers including the MRCF and Yuuwa Capital to fund further clinical studies.
Profile of Agworld, a farm management platform founded in 2009, covering its agronomist-focused go-to-market, data rules of engagement, investor relationships, and its recalled $1.5 million Series A led by Yuuwa Capital.